Dan G Duda

48PUBLICATIONS
244CO-AUTHORS
Radiation therapyMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Oct 22, 2026
Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors.

|Oct 08, 2026
Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.

|Dec 08, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Xin Liu, Zelong Liu, Chengzhan Zhu

|May 05, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Xin Liu, Zelong Liu, Tatsuya Kobayashi

|Mar 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Xin Liu, Zelong Liu, Tatsuya Kobayashi

|Jan 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.

Jun Ren, Zohreh Amoozgar, Taylor P Uccello

Pageof 8

Frequent Collaborators

14 joint publications

Rakesh K Jain

8 joint publications

Dai Fukumura

5 joint publications

Pin-Ji Lei

5 joint publications

Xin Liu